Infosys Escalates U.S. Antitrust Case Against Cognizant Over Helix Rivalry

Bangalore, July 2025 – Infosys, a leading Indian IT services giant, has intensified its antitrust lawsuit in the United States against Cognizant Technology Solutions by naming two senior executives—Surya Gummadi (President, Americas) and Kathryn Diaz (Chief People Officer)—as central figures in its legal claims.

This move is part of a broader legal battle stemming from Cognizant’s 2014 acquisition of TriZetto, a U.S.-based healthcare software company that directly competes with Infosys’ own Helix platform.


⚖️ Infosys Alleges Anti-Competitive Practices

According to a joint court filing dated June 13, Infosys accuses Cognizant of monopolistic tactics and using its acquisition of TriZetto to undermine fair competition in the healthcare IT services market.

The filing states that both Gummadi and Diaz have “personal knowledge and unique involvement” in Cognizant’s strategy. Infosys is requesting access to key internal documents to support its claims.


💸 What’s at Stake?

Infosys is seeking treble damages—potentially amounting to hundreds of millions of dollars—if the court rules in its favor. The company also asserts that the antitrust issues go beyond trade secrets and involve systematic attempts to disrupt fair market dynamics.


🔍 Key Allegations Against Cognizant

  • Ravi Kumar S, current Cognizant CEO and former Infosys President, allegedly delayed the rollout of Infosys Helix during his transition.

  • Infosys claims Kumar later poached critical Helix team members, including Shveta Arora and Ravi Kuchibhotla, after becoming CEO at Cognizant.

  • Diaz, appointed as Chief People Officer by Kumar, allegedly played a key role in Cognizant’s recruitment tactics, targeting Infosys’ healthcare IT team.


🏥 Healthcare IT Market in Focus

The lawsuit centers around one of the most competitive verticals in IT services:

  • Cognizant: Earns approx. $5.9 billion (~33% of total revenue) from healthcare technology.

  • Infosys: Generates $1.4 billion (~7.3% of revenue) from its healthcare IT offerings.

Both companies are major players in Bangalore’s IT talent market, offering numerous opportunities for fresher and experienced professionals.


🗣️ Cognizant’s Response

Cognizant strongly denied Infosys’ claims, stating:

“Infosys’ ongoing obfuscation does not change the fact that they have been caught red-handed stealing Cognizant’s intellectual property. The allegations are baseless and legally deficient.”


🧾 Legal Outlook: What’s Next?

A U.S. court has encouraged both companies to pursue an informal resolution, but Infosys appears ready to proceed with full litigation if talks fail. The outcome of this case could have significant implications for talent mobility, innovation, and competition in the IT services industry.


📌 Source:

Infosys names two more Cognizant execs in antitrust case – The Economic Times


📝 Disclaimer:

This article is a summarized interpretation of publicly available information intended for educational and informational purposes only. It is not affiliated with Infosys, Cognizant, or The Economic Times

Leave a Comment

error: Content is protected !!